Illia Mariutsa

Mr. Illia Mariutsa

National University of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
HHHalyna Hryhoriv
Halyna Hryhoriv
Illia MariutsaIllia Mariutsa
Illia Mariutsa
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
LPLina Perekhoda
Lina Perekhoda
LSLyudmila Sidorenko
Lyudmila Sidorenko
Among all modern antibiotics, fluoroquinolones are well known for their broad spectrums of activity and efficiency toward microorganisms and viruses. However, antibiotic resistance is still a problem, which has encouraged medicinal chemists to modify the initial structures in order to combat resistant strains. Our current work is aimed at synthesizing novel hybrid derivatives of ciprofloxacin and norfloxacin and applying docking studies and biological activity evaluations in order to find active promising molecules. We succeeded in the development of a synthetic method towards 1,2,3-triazole-substituted ciprofloxacin and norfloxacin derivatives. The structure and purity of the obtained compounds were confirmed by 1H NMR, 13C NMR, 19F NMR, LC/MS, UV-, IR- spectroscopy. Docking studies, together with in vitro research against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Bacillus subtilis ATCC 6633, Pseudomonas aeruginosa ATCC 27853, Candida albicans NCTC 885-653 revealed compounds in which activity exceeded the initial molecules.

29 October 2021 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
HHHalyna Hryhoriv
Halyna Hryhoriv
Illia MariutsaIllia Mariutsa
Illia Mariutsa
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
LSLyudmila Sidorenko
Lyudmila Sidorenko
LPLina Perekhoda
Lina Perekhoda
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
The aim of the work. Among all the representatives of four generations of fluoroquinolones ciprofloxacin (CIPRO) and norfloxacin (NOR) remain widely used and prescribed antibiotics in clinical practice. However, the problem of resistance towards them is gradually increasing. Thus, our investigation is dedicated to chemical modification of C-7 position of Ciprofloxacin and Norfloxacin ring as a promising solution to combat antibiotic resistance and open a pathway towards convenient synthesis of new fluoroquinolones derivatives. Materials and methods. The subjects of the research were N-piperazine-substituted ciprofloxacin and norfloxacin. The methods of molecular docking and organic synthesis were applied in the study. The structures of the obtained compounds were confirmed by 1H NMR, 13C NMR, 19F NMR, LC/MS, IR, UV spectroscopy. The antimicrobial activity was measured by the method of double serial dilutions against Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), Bacillus subtilis (ATCC 6633), Pseudomonas aeruginosa (ATCC 27853), Candida albicans (NCTC 885-653) and diffusion in agar method against clinical strains. The results. 7-(4-(2-Cyanoacetyl)piperazin-1-yl)-1-R-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids were synthesized and their structures were confirmed. The obtained compounds showed the antibacterial activity on the reference level for double dilution method and exceeded control for “well” method. Conclusions. The current investigation revealed the promising route for the expanding of the existing fluoroquinolones diversity. Pharmacodynamics and pharmacokinetics changes could be achieved by chemical modifications of C-7 position of the initial ring. Further research utilizing the obtained compounds as starting ones opens a promising way to novel active molecules synthesis and combating the problem of antibiotic resistance

24 March 2020 in Journal of Sulfur Chemistry
Verified
Journal Article
Closed access
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
ODOleksandr Drushlyak
Oleksandr Drushlyak
Illia MariutsaIllia Mariutsa
Illia Mariutsa
Novel 1-substituted-5-thioxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-1-ium-2-thiolates have been obtained by base catalyzed condensation of methyl 2-isothiocyanatobenzoate with thiosemicarbazides. The reaction occurs via intermediate N-(4-oxo-2-thioxo-1,4-dihydroquinazolin-3(2H)-yl)thioureas followed by cyclization with elimination of the oxygen atom as water and the angular product formation. All new synthesized compounds were fully characterized with elemental and spectroscopic analysis.

16 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
ODOleksandr Drushlyak
Oleksandr Drushlyak
SSSvitlana Shishkina
Svitlana Shishkina
IKIrina Konovalova
Irina Konovalova
Illia MariutsaIllia Mariutsa
Illia Mariutsa
TLThierry Langer
Thierry Langer
Consecutive alkylation of 4-hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate by CH3I has been investigated to establish regioselectivity of the reaction for reliable design and synthesis of combinatorial libraries. In the first stage, the product of S-methylation-methyl 4-hydroxy-2-(methylthio)quinoline-3-carboxylate was obtained. The subsequent alkylation with CH3I led to the formation of both O- and N-methylation products mixture-methyl 4-methoxy-2-(methylthio)quinoline-3-carboxylate and methyl 1-methyl-2-(methylthio)-4-oxo-1,4-dihydroquinoline-3-carboxylate with a predominance of O-methylated product. The structure of synthesized compounds was confirmed by means of elemental analysis, 1H-NMR, 13C-NMR, LC/MS, and single-crystal X-ray diffraction. The quantum chemical calculations of geometry and electron structure of methyl 4-hydroxy-2-(methylthio)quinoline-3-carboxylate’s anion were carried out. According to molecular docking simulations, the studied compounds can be considered as potent inhibitors of Hepatitis B Virus replication. Experimental in vitro biological studies confirmed that studied compounds demonstrated high inhibition of HBV replication in 10 µM concentration.

14 October 2019 in Molbank
Verified
Journal Article
Open access
PDF file
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
ODOleksandr Drushlyak
Oleksandr Drushlyak
IKIrina Konovalova
Irina Konovalova
Illia MariutsaIllia Mariutsa
Illia Mariutsa
DKDmitry V. Kravchenko
Dmitry V. Kravchenko
OMOleg Mitkin
Oleg Mitkin
A new suitable method of synthesis of methyl 4-hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate by condensation of methyl 2-isothiocyanatobenzoate and methyl malonate is described. The structure of the compound both and by-product methyl 2-(methoxycarbonothioylamino)benzoate was confirmed by means of elemental analysis, 1H NMR, 13C NMR, LC/MS and single crystal X-ray diffraction. UV/Vis and IR spectra of compounds are described. The presence of a strong intramolecular hydrogen bond between the hydroxy group and the carbonyl oxygen atom of the ester group in methyl 4-hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate is shown. The crystal structure of product was stabilized through intermolecular hydrogen bonds.